# Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With Sepsis

> **NCT00559130** · NA · COMPLETED · sponsor: **MedaSorb Technologies, Inc** · enrollment: 100 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome
- Acute Lung Injury
- Sepsis

## Interventions

- **DEVICE:** CytoSorb Hemoperfusion

## Key facts

- **NCT ID:** NCT00559130
- **Lead sponsor:** MedaSorb Technologies, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-04
- **Final completion:** 2011-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559130, "Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With Sepsis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00559130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*